Last Updated: September 24, 2026

Details for New Drug Application (NDA): 021234

✉ Email this page to a colleague

NDA 021234 describes FLECTOR, which is a drug marketed by Ibsa and is included in one NDA. It is available from thirteen suppliers. Additional details are available on the FLECTOR profile page.

The generic ingredient in FLECTOR is diclofenac epolamine. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the diclofenac epolamine profile page.

Summary for 021234

Tradename:	FLECTOR
Applicant:	Ibsa
Ingredient:	diclofenac epolamine
Patents:	0

Pharmacology for NDA: 021234

Mechanism of Action	Cyclooxygenase Inhibitors
Physiological Effect	Decreased Prostaglandin Production

Suppliers and Packaging for NDA: 021234

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234	NDA AUTHORIZED GENERIC	Teva Pharmaceuticals USA Inc.	0093-3727	0093-3727-55	6 POUCH in 1 CARTON (0093-3727-55) / 5 SYSTEM in 1 POUCH (0093-3727-50)
FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234	NDA AUTHORIZED GENERIC	Preferred Pharmaceuticals Inc.	68788-4115	68788-4115-3	6 POUCH in 1 CARTON (68788-4115-3) / 5 SYSTEM in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SYSTEM;TOPICAL			Strength	1.3%
Approval Date:	Jan 31, 2007	TE:		RLD:	Yes

Expired US Patents for NDA 021234

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ibsa	FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234-001	Jan 31, 2007	4,948,805	⤷ Start Trial
Ibsa	FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234-001	Jan 31, 2007	5,607,690	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.